Michael Hamblin

ORCID iD
https://orcid.org/0000-0001-6431-4605
  • Keywords
  • Show details Hide details
photomedicine,

Sources:
Michael Hamblin (2017-10-13)

photobiomodulation,

Sources:
Michael Hamblin (2017-10-13)

photodynamic therapy,

Sources:
Michael Hamblin (2017-10-13)

new photosensitizers,

Sources:
Michael Hamblin (2017-10-13)

antimicrobial photodynamic inactivation,

Sources:
Michael Hamblin (2017-10-13)

nanomedicine,

Sources:
Michael Hamblin (2017-10-13)

drug delivery

Sources:
Michael Hamblin (2017-10-13)

  • Websites
  • Show details Hide details
homepage

Sources:
Michael Hamblin (2017-10-13)

amazon author page

Sources:
Michael Hamblin (2017-10-13)

DFHCC

Sources:
Michael Hamblin (2017-10-13)

Mendeley Profile

Sources:
Michael Hamblin (2018-07-06)

Scopus Profile

Sources:
Michael Hamblin (2018-07-06)

  • Other IDs
  • Show details Hide details
Scopus Author ID: 7004296356

Sources:
Scopus - Elsevier (2013-06-29)

Scopus Author ID: 55942123300

Sources:
Scopus - Elsevier (2017-07-25)

Biography

Michael R Hamblin Ph.D. is a Principal Investigator at Wellman Center for Photomedicine, Massachusetts General Hospital, and an Associate Professor Harvard Medical School. He has interests in photodynamic therapy and photobiomodulation. He has published 422 peer-reviewed articles, is Editor-in-Chief of “Photobiomodulation, Photomedicine and Laser Surgery”, Associate Editor for 10 other journals, and serves on NIH Study-Sections. He has an h-factor 90 and >32,300 citations. He has authored/edited 23 textbooks on PDT and photomedicine including SPIE proceedings. Dr Hamblin was elected as a Fellow of SPIE in 2011, received 1st Endre Mester Lifetime Achievement Award Photomedicine from NAALT in 2017, and Outstanding Career Award from Dose Response Society in 2018.

Record last modified {{lastModifiedDate}}